Watson Investigational Site 119 — Jenkintown, Pennsylvania

Watson Investigational Site 119 is a clinical research site located in Jenkintown, Pennsylvania, United States 19046.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Watson Investigational Site 119 has participated in 1 clinical trials.

Therapeutic areas: Leiomyoma, Uterine Hemorrhage.

Sponsors: Allergan.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jenkintown

Browse all research sites in Pennsylvania · View every site in Jenkintown

• The Clinical Trial Center
• Research Site
• GSK Investigational Site
• Pfizer Investigational Site
• Teva Investigational Site 13591
• Clinical Trial Center
• Novo Nordisk Investigational Site
• Clinical Trial Site
• BioSante Site 165
• Foamix Investigational Site # 141
• Investigator Site - Jenkintown
• Warner Chilcott Investigational Study Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Watson Investigational Site 119?

Watson Investigational Site 119 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Watson Investigational Site 119 conducted?

Watson Investigational Site 119 has 1 clinical trials on record. Their work covers Leiomyoma, Uterine Hemorrhage.

Is Watson Investigational Site 119 accredited by Crixeo Clinical Trials?

Watson Investigational Site 119 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Watson Investigational Site 119?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.